We really can’t forecast all that well and yet we pretend that we can but we really can’t.
Alan Greenspan, quoted on The Daily Show, 20131
Corporate finance is part of strategic thinking because collectively managers must assess, implement and evaluate a given course of future action in terms of its ability to create or destroy value. The most common metrics used to measure this are financial. In Part 2 we looked at finance in terms of reporting past performance, but this is not the same thing as valuing the business. A business is worth what it can be expected to do in the future. Corporate finance is about systematically choosing a course of action that will create value in the future.
You don’t have to be the manager making the big, strategic decisions for corporate finance to be important. The fact is that you are already involved, because those decisions need implementing and you must align what you do to an overall direction. Look back now at the McKinsey 7-S framework. Imagine how each of those elements needs to be aligned for the organisation to maintain balance. In a similar way, knowing more about why your organisation has the capital structure and investments it does makes it easier for you to understand the purpose of your job. Later in your career it could be you deciding which plans to implement, so an understanding of the language and theory of corporate finance will be crucial then.
Arrange to speak with your chief financial officer. Ask them to explain the capital structure of your organisation. What is the balance between equity and debt (gearing)? How is it appropriate to the goals of your organisation?
First we need to restate as plainly as possible what value looks like in finance terms. An organisation with no cash (or access to cash) has no future. It follows that an organisation must be concerned with how it will continue to generate enough cash in the future to fulfil the task of value creation. To do this, senior management has to make three kinds of decision:
Sounds straightforward. As you might expect, though, there are some caveats:
Nevertheless, wealth creation remains at the heart of value measurement as it is taught at business school. Wherever you work, fiduciary duty affects what you do. So, let’s look at corporate finance decisions through five lenses: governance, valuation, risk management, value and financing. I will focus on what these concepts mean for you as a manager in your day-to-day work rather than what they might mean to an investor (the literature in that area is vast).
We saw in Chapter 1 that representing the interests of the owners or founders is a basic management task. Shareholders are supposed to trust that managers will make decisions without the need for constant monitoring, and managers are supposed not to put their own reward ahead of the interests of the shareholders. This responsibility is called fiduciary duty and is a legal relationship between the principal (owner) and agent (manager).
That relationship, called governance, is what is called for in agency theory. In an ideal world – in theory – managers will act only to maximise the interests of owners or shareholders and not to further their own to the detriment of shareholders. Agency theory states that this needs to be governed to make sure that managers don’t put their own wealth first. Governance makes sure that activity carried out by managers is not in conflict with owner interests. It tries to mitigate this risk by incentivising senior managers, often with performance-based inducements such as bonuses or shares, to fulfil their fiduciary duty and create value.
It will help to understand the differences between management and governance:
– | Make day-to-day decisions to execute a strategy. |
– | To ‘do things right’. |
– | Align their actions with the boundaries set by the governing body. |
Boards are appointed by shareholders to undertake this setting of direction and upholding of values and to monitor and check the work of management. They are not involved in the day-to-day running of the business.
What is the governance structure of your organisation? Find out what you can about the people who are in governance roles in your organisation.
In early 2014 US pharmaceutical giant Pfizer was repeatedly rebuffed in a ‘friendly’ takeover by the board of AstraZeneca. This is how the Financial Times summed up the news in its weekly review:
Pfizer’s politically controversial £69.4bn pursuit of AstraZeneca came to an end this week with the US pharmaceutical company finally admitting defeat. It abandoned the month-long takeover battle for its British rival two hours before the Monday deadline for a deal to be struck under UK takeover rules.
It marks a rare failure for a company that has prevailed in a series of huge deals in the past 15 years. But it brought relief to UK politicians and scientists who were concerned over the deal’s potential impact on AstraZeneca’s nearly 7,000-strong UK workforce.
Attention has now switched to whether Pfizer will launch another approach when the mandatory six-month cooling-off period ends, with investors in AstraZeneca, including its largest, BlackRock, signalling a desire for renewed talks. Although Ian Read, Pfizer’s chairman and chief executive, gave no clear sign that was likely, he also failed to rule it out.
Both companies have been criticised by shareholders for letting the deal fail, with AstraZeneca accused of rejecting the £55-a-share proposal too hastily, and Pfizer was questioned for declaring the offer as final – making it impossible to raise the bid.
AstraZeneca will now be under intense pressure to deliver promised growth.
Pfizer had planned to shift its tax residence to the UK in the event of a deal – the most high-profile attempt so far by an American multinational group to shelter its offshore revenues from US taxation.
Source: Wilson, N., ‘WEEK IN REVIEW – PHARMACEUTICALS – Pfizer walks away from controversial Astra offer’, The Financial Times, 31 May 2014. © The Financial Times Limited. All Rights Reserved.
What is interesting in this case is that, amid enormous media interest, successive offers from Pfizer were rejected by the AstraZeneca board. While the popular press focused on the emotive politics of a threat to jobs post-merger and loss of British identity in the sector (despite AstraZeneca’s global reach and Swedish co-ownership), financial media coverage looked into the governance aspects of the proposed move. The background was analysed from several angles, including strategic marketing (match of respective brand portfolios, access to R&D for new product pipeline), corporate finance (cash flows drying up due to the ‘cliff’s edge’ of expiring patents) and governance (avoiding tax, dividends payments for shareholders, share price).
What made the difference here? It’s unlikely to be a question of politics. As many insiders were reported as saying, ‘price trumps politics’, and any deal – now or in the future – will hang on the vested interests of the shareholders of both companies. Pfizer’s long-term strategy may have been to bring together two large companies in order to de-merge them later on and take advantage of the new drug pipeline acquired from AstraZeneca. The story will no doubt continue to evolve.
It is a board’s responsibility to create value as a return on money invested by shareholders. Therefore they need to understand not just the performance of the business but also how much it is worth – its valuation. They will be the ones who make decisions about buying or selling parts of the business (or acquiring others), so it’s vital for them to know what the return is, or will be, as generated by a particular investment. Governance addresses risk (and therefore financial risk) as well as valuation. Management and governance need to coordinate for a business to work well.
Senior management is expected to act to maximise shareholder value and minimise risks found in long-term financial planning. Shareholder value is measured using discounted cash flows (DCF), which allows the organisation to address two questions:
Because of inflation the value of money will decrease over time unless invested. Fiduciary duty means that management must look for, and then be able to justify and evaluate, the best future plan to create wealth. You may have many possible courses of action available to you, so you need a way to compare like with like. The most common way to do this is by an NPV calculation, which is the total present worth of a series of future cash flows that has been discounted at a specified rate.
In finance terms, value is created when companies invest at returns that exceed the opportunity cost of capital (OCC) and this is the minimum expectation for any project in its terminal value at the end of the planning period. OCC is a key concept in corporate finance because the money working in one place is missing the ‘opportunity’ of working somewhere else and it establishes the measure of performance of an investment in a commercial organisation. The time during which economic return exceeds the hurdle rate (for example, the OCC) is known as the competitive advantage period (CAP). Beyond CAP, the advantage diminishes as returns are eroded to a point where no additional value is being produced. Context means that what is ‘long-term’ in one industry may be ‘short-term’ in another, and different parts of different businesses assess things in different ways. Critically, in all cases the past is no guarantee of the future. A planning period will end with a hypothetical point at which you expect your competition to catch up, so to continue to generate value there must then be further investment, and the cycle goes on.
While these principles are known to all players, there is enormous scope for qualitative judgement (and misjudgement) and no amount of number crunching will replace business acumen and experience. Here is where corporate finance meets the many internal and external forms of analysis featured in earlier chapters.
1 | How aligned to future value creation is your organisation’s business model? |
2 | What is long-term in your industry or sector? How are long-term investments identified in your organisation? |
The valuation of debt covers borrowings, although here, as with equity, there is complexity and volatility (think about the jungle of traded derivative instruments or the background to the US subprime mortgage collapse in 2007), but since prices for most sources of debt are determined by open-market supply and demand, a market rate is available to determine OCC. The initial basis for that rate is the interest earned on government bonds because they deliver a (virtually) risk-free return.
Any uncertainty about the future represents risk, so adjustments for this will also be built into the calculation of a discount rate. There are three broad categories of metrics:
Higher risk suggests higher return, which in most for-profit companies is an attractive proposition. It also has a downside, of course, if the venture fails to produce returns. The future value of risk is therefore reflected in calculations of the cost of capital. Financial economists distinguish between two types of risk:
As nervous entrepreneurs pitching unrealistic valuations on the popular TV show Dragons’ Den often find to their cost, the value of a company is tied to future cash flows. Every business is different, but management must take into account all the risk factors appropriate to its sector, size and life-cycle maturity, as well as the whole host of internal and external concerns that we looked at in earlier chapters.
Shareholder value analysis (SVA) is what corporate finance has substituted for traditional business measurements in many parts of the world. Shareholders’ capital is supposed to earn a higher return than by investing in other assets with the same amount of risk. If a company sees equity returns higher than equity costs, value is created. When that value is known, the organisation can act on this to improve its performance, as well as work out how successful past projects have been. Shareholder value can be determined by discounting the expected cash flows to the present at the weighted average cost of capital. So far we have looked at finance only from the perspective of for-profit enterprises, which aim at generating free cash flows for their owners or shareholders.
The investment side of corporate finance covers stocks, shares and financial markets for managing investments and risk and would take more than a section in this book to cover. Since our focus is on the types of decisions middle and senior management need to make internally, knowing how a particular investment or project is attractive in value terms is more important.
The attractiveness of a proposed course of future strategic action is determined by its discounted cash flows. This brings us back to the capital structure of an organisation and to the weighted average cost of capital (WACC), which is a calculation of opportunity costs averaged across the capital structure of the organisation, reflecting the risks associated with debt and equity. WACC is a calculation of the percentage and cost of debt plus the percentage and cost of equity. The function of a corporate WACC is as a discount rate. In other words, the level of return on capital needed for an investment must be better than employing that debt or equity elsewhere. This approach is part of value-based management (VBM).
VBM, though, is under severe scrutiny following the near collapse of the economic system in many of the world’s mature economies. When all that matters is that every decision is evaluated in terms of the effect on shareholder wealth, the dynamic between the owners and the managers acting on their behalf is thrown into sharp contrast.
It is worth noting here that things are a little different in the case of not-for-profits (e.g. community groups, charitable trusts, non-governmental organisations (NGOs), social enterprises), where the aim is not to accrue wealth but to serve the aims of members by maximising the marginal effect of operations on the capital donated. Value here means human well-being. Can this still be measured by cash flows? Not exactly, but the idea of the time value of money is still useful to evaluate competing options for long- or short-term welfare benefits.
In many countries, the funding of the health care sector (especially if it is a public service funded by the state) is a significant – and complex – subset of valuation because it is not always obvious how to put a monetary value on health benefits. Should only the costs of interventions be compared, or rather costs versus benefits?
SMEs cannot generate the kind of data for the capital assets pricing model (CAPM) or for beta calculations, so the quickest solution is to replace many of the variable elements of SVA with market-driven substitutes (for example, by identifying and using the betas of traded companies with similar debt/equity ratios and similar economic influences). Value in SMEs is a broader concept than in traded companies, so the market value is often seen as being the price the owners would get if they were to sell the company. That may be arrived at by:
1 | How good do you think the discounted cash flow method is for valuing a not-for-profit? |
2 | What role do you think the personality of the owners plays in valuing an SME? |
Financial planning combines strategic decision making with the capital structure of the whole organisation into the future. Chapter 5 established where this process begins – with awareness of the current situation using financial statements and ratios. There is a lot of wriggle room for interpretation in statistics and ratios, so when it comes to planning rather than formulaic answers, you want this information to provide good, common-sense questions about the long term. When you get down to it, planning for the long term (i.e. beyond the coming 12 months) involves the following:
We’ve seen that the main sources of funding for future growth and investment are equity and debt.
Equity is money invested in the business by shareholders, usually in the form of shares. Additional money may be raised by the sale of new shares and usually this is in the expectation that funds will go towards non-current assets. Equity attracts returns in the future through payments of dividends from excess residual funds, but equity holders carry more risk (they are not first in line for repayment) so will expect a higher rate of return, which they will also discount to present value to make sure it is invested well. Shareholders are closer to the running of a business than financial institutions, so this can bring additional pressure to bear on senior management to aim for short-term gains.
Debt, meanwhile, is money lent to the business by investors or financial institutions without the expectation of a say in the aims or purpose of the business. Debt offers a fixed claim to interest payments and may offer a slightly lower cost of capital than equity because the lender knows that they have preferred status for repayment. Finding the right balance of long-term funding is not easy. Many companies try to match long-term assets to long-term borrowings or equity, but prefer to maintain liquidity in working capital financed from inventories or short-term securities.
Capital budgeting is the annual listing of major investment projects and these are expenditures that will, presumably, bring some future benefit if properly implemented. All such decisions must consider:
The ratios mentioned in Chapter 5 can be useful in addressing some of these issues because they are all in relationship with the capital structure. What you as a general manager are looking for is:
This leads to the further question of the best sources of capital, because as we have seen above, equity and debt carry different costs and can have implications for valuation. All of these options will produce changes to the capital structure, which is why it is important to find out from your finance staff what is appropriate for your organisation. Organisations may change their capital structure in more radical ways. Here are just a few:
1 | Take another look at what your organisation does. How do you see it in light of what has been discussed in Part 3 so far? What has changed in your perception? |
2 | What are the new questions you have about your own role? Make some notes. |
Corporate governance is what ties together the various strands in this chapter. Governance and agency theory refer to the structures in place in an organisation to represent and protect the interests of owners and shareholders. If the agent possesses asymmetrical information of a kind that may damage or destroy shareholder value, it could lead to dilemmas, such as:
In some countries governance of larger, publicly traded companies is legislated for and codified. Structures that organisations put in place to mitigate the risks of governance failures include managerial incentive schemes, takeovers, board of directors, pressure from institutional investor, product market competition and organisational structure, all of which can be thought of as constraints that affect the process through which risk and returns are distributed.
A classic text: | The Wealth of Nations by Adam Smith (1982), Penguin Classics. The book that brought us ‘the invisible hand’ and ‘the division of labour’, Smith’s 200-year-old classic was one of the first explorations of the market economy. |
Going deeper: | 23 Things They Don’t Tell You About Capitalism by Ha-Joon Chang (2011), Penguin Books. An accessible, thought-provoking and well-researched presentation of a macroeconomic viewpoint that challenges many of our norms. |
Watch this: | ‘Sir Adrian Cadbury reflects on properly constituted audit committees and boardroom self-evaluation.’ An interview with the chair of the Cadbury Committee on corporate governance, part of the wide range of additional business materials freely available online: http://youtu.be/ZfC7ykLKy4M |
1 www.businessinsider.com/alan-greenspan-on-the-daily-show-2013-10
1 | Reflect on the best and worst pieces of financial advice that you have received in your life, or your best and worst experiences with money. What advice would you pass on to others? |
2 | Do you have a long-term financial plan? Do you want to retire in the traditional sense? What do you see yourself doing at that age? |